Literature DB >> 20198623

NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells.

Adam W Mailloux1, Anna-Maria A Clark, M Rita I Young.   

Abstract

Tumor-induced immune suppression involves the accumulation of suppressive infiltrates in the tumor microenvironment such as regulatory T-cells (Tregs). Previous studies demonstrated that NK-dependant increases in CCL22 secretion selectively recruit Tregs toward murine lungs bearing Lewis Lung Carcinoma (LLC). To extend the in vitro studies, the present studies utilized in vivo depletion of NK cells to ascertain the contribution of NK-derived CCL22 toward total CCL22 and subsequent Treg levels in both normal and LLC-bearing lungs. However, NK depletion had the unexpected effect of increasing both CCL22 secretion and Treg levels in the lungs of NK-depleted LLC-bearing mice. This was concurrent with an increase in tumor burden. Flow cytometry and a series of both immunomagnetic and FACS isolations were used to identify the CCL22-producing cellular fractions in LLC-bearing lungs. A novel CD11b(+)CD11c(+) cell population was identified that accumulates in large numbers in NK-depleted LLC-bearing lung tissue. These CD11b(+)CD11c(+) cells secreted large amounts of CCL22 that may overcompensate for the loss of NK-derived CCL22 in the lungs of NK-depleted LLC-bearing mice. Taken together, these data suggest that NK cells play both a positive and negative role in the regulation of CCL22 secretion and, in turn, the recruitment of Tregs toward LLC-bearing lungs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198623      PMCID: PMC2947555          DOI: 10.1002/ijc.25281

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Authors:  M J Smyth; N Y Crowe; D I Godfrey
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

2.  Regulation of cutaneous malignancy by gammadelta T cells.

Authors:  M Girardi; D E Oppenheim; C R Steele; J M Lewis; E Glusac; R Filler; P Hobby; B Sutton; R E Tigelaar; A C Hayday
Journal:  Science       Date:  2001-09-20       Impact factor: 47.728

3.  NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.

Authors:  K Suzuki; H Nakazato; H Matsui; M Hasumi; Y Shibata; K Ito; Y Fukabori; K Kurokawa; H Yamanaka
Journal:  J Leukoc Biol       Date:  2001-04       Impact factor: 4.962

4.  NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

Review 6.  The three Es of cancer immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 7.  Human CD4+CD25+ regulatory T cells.

Authors:  Clare Baecher-Allan; Vissia Viglietta; David A Hafler
Journal:  Semin Immunol       Date:  2004-04       Impact factor: 11.130

8.  Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.

Authors:  Amy C Peterson; Helena Harlin; Thomas F Gajewski
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

9.  Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.

Authors:  A Iellem; M Mariani; R Lang; H Recalde; P Panina-Bordignon; F Sinigaglia; D D'Ambrosio
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

10.  Differential tumor surveillance by natural killer (NK) and NKT cells.

Authors:  M J Smyth; K Y Thia; S E Street; E Cretney; J A Trapani; M Taniguchi; T Kawano; S B Pelikan; N Y Crowe; D I Godfrey
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  9 in total

1.  A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer.

Authors:  Hideki Shimaoka; Shinsuke Takeno; Kenji Maki; Takahide Sasaki; Suguru Hasegawa; Yuichi Yamashita
Journal:  Oncol Lett       Date:  2017-06-23       Impact factor: 2.967

Review 2.  Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.

Authors:  Rinat Zaynagetdinov; Taylor P Sherrill; Linda A Gleaves; Allyson G McLoed; Jamie A Saxon; Arun C Habermann; Linda Connelly; Daniel Dulek; R Stokes Peebles; Barbara Fingleton; Fiona E Yull; Georgios T Stathopoulos; Timothy S Blackwell
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

Review 4.  The suppressive tumor microenvironment: a challenge in cancer immunotherapy.

Authors:  Elizabeth A Vasievich; Leaf Huang
Journal:  Mol Pharm       Date:  2011-05-05       Impact factor: 4.939

5.  Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.

Authors:  Gabriela Maria Wiedemann; Max Martin Ludwig Knott; Viola Katharina Vetter; Moritz Rapp; Sascha Haubner; Julia Fesseler; Benjamin Kühnemuth; Patrick Layritz; Raffael Thaler; Stephan Kruger; Steffen Ormanns; Doris Mayr; Stefan Endres; David Anz
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 6.  Regulation of chemokine expression in the tumor microenvironment.

Authors:  Anton V Gorbachev; Robert L Fairchild
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

7.  Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS.

Authors:  Maarten A Ligtenberg; Özcan Çınar; Rikard Holmdahl; Dimitrios Mougiakakos; Rolf Kiessling
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

8.  Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy.

Authors:  Yung-Che Chen; Chang-Chun Hsiao; Kuang-Den Chen; Yu-Chiang Hung; Ching-Yuan Wu; Chien-Hao Lie; Shih-Feng Liu; Ming-Tse Sung; Chung-Jen Chen; Ting-Ya Wang; Jen-Chieh Chang; Petrus Tang; Wen-Feng Fang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Sum-Yee Leung; Mao-Chang Su; Chin-Chou Wang; Meng-Chih Lin
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 9.  Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress.

Authors:  Meriem Hasmim; Yosra Messai; Linda Ziani; Jerome Thiery; Jean-Henri Bouhris; Muhammad Zaeem Noman; Salem Chouaib
Journal:  Front Immunol       Date:  2015-09-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.